About this Research Topic
Nanomaterials have high biocompatibility, directional targeting and selectivity, which can effectively target tumor cells in tumor research, reduce adverse reactions in patients, reduce drug dose, and improve therapeutic effect. In the future, nanomaterials may improve or even replace traditional treatment methods and be applied to human tumors, playing a crucial role in tumor prevention, tumor screening, clinical diagnosis, anti-tumor therapy, and other aspects, improving patient prognosis and improving patient quality of life. In order to promote the clinical transformation of nanomaterials, basic research is very necessary, including improving the properties of materials, preparing new materials, exploring new application areas, and improving nanomanufacturing technology. To strengthen the control of safety and effectiveness in the design, synthesis, and application of nanomaterials, so that they can truly become a powerful tool for the treatment of tumors.
The themes of this Research Topic include, but are not limited to:
• Research on Nanomaterials in Tumor Diagnosis
• Research on Nanomaterials in Tumor Therapy
• Nanoparticles-mediated delivery of anti-tumor agents
• Nanomaterials enhance tumor immunity by modulating the immune microenvironment
• Nanomaterials target to track and kill distant metastatic tumor cells
• Nanomaterials reprogram tumor metabolism
• Nanomaterials improve tumor drug resistance
• Nanomaterials enhance the effects of traditional treatments
• Application of nano drug delivery platform in tumor
• Precise anti-tumor therapy through tumor enrichment of nanomaterials
• Anti-tumor vaccines prepared based on nanomaterials
• Applications of cutting-edge nanomaterials in cancer
Keywords: Nanoparticles, Nanomaterials, cancer therapeutics, Biomarkers, Tumor immunity, Tumor Microenvironment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.